| 1 | Approve Company Financial Statements | |
| 2 | Presentation of the Group's Report and Financial Statements | |
| 3 | Approval of the appropriation of income and of the dividend | |
| 4 | Approval of regulated related-party agreements | |
| 5 | Discharge of the Board | |
| 6 | Reappointment of M. Michael Diekmann as Director for a period of 4 years. | |
| 7 | Non-renewal of a member of the Board, Antoine Jeancourt-Galignani as Director | |
| 8 | Increase authorized capital by transfer of reserves : Authorize an operation up to 650 000 000 in nominal value; authorization valid for a period of 26 months ; | |
| 9 | Global authorization to issue with pre-emptive subscription right shares or other securities giving way to new capital Authorize an operation up to 650 000 000 in nominal value; Authorize the issuance of related securities up to an amount of 1 500 000 000 . authorization valid for a period of 26 months ; | |
| 10 | 1)Global allowance for the issuance of capital related securities without pre-emptive right;2)"Green shoe" authorization | |
| 11 | Limit capital Increases with or without pre-emption rights. | |
| 12 | Delegation to issue shares and capital securities as consideration for contributions in kind made to the company | |
| 13 | Approve capital Increase for the employees : | |
| 14 | Delegation of powers for the completion of formalities | |
